Company intelligence / Profile preview

MORPHEE+

Ownership: Private
Development stage: Other

Overview

MORPHEE+ provides real-time fall detection and monitoring for patients receiving home care. The system aims to improve patient safety while preserving privacy. No clinical trial data typical of therapeutics; product appears to be commercially available.

Therapeutic areas: Other
Modalities: DeviceNon-pharmacological therapy
Industry: Physiological Monitoring

Partnerships

SATT Paris-SaclayONERA

Beyond the preview

Go deeper on MORPHEE+.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MORPHEE+.

Explore the full profile